Cour Pharmaceuticals Development

0 followers

‌

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

Industries

Biotechnology, Pharmaceutical

Headquarters

Elmhurst, United States

Employees

11-50

Links

Org chart

John J. Puisis

Co-Founder & President & CEO

John J. Puisis

Collapse

Brian C. Bock

CFO

Dannielle Appelhans

President And Chief Executive Officer

Adam Elhofy

VP, Immunology & Innovation

Robert Hodge

VP of Technical Development

Pooja Agashe

Intellectual Property and Business Analyst

Sandeep Kakade

Senior Formulations & Product Development Scientist

Lori Jester

Vice President Of Manufacturing And Supply Chain

Ashorena Michael

Accountant

Teams

Advisory and Executive Roles

12 members

Research and Development

10 members

Leadership Team

8 members

Finance and Accounting

4 members

Regulatory Affairs and Compliance

3 members

Similar companies

Amgen

215 followers

Umoja Biopharma

3 followers

Tessera Therapeutics

2 followers

Vaxcyte

2 followers

Vera Therapeutics

2 followers

Neogene Therapeutics

2 followers

AbbVie

178 followers

Incyte

15 followers

Apogee Therapeutics

1 follower

Recursion Pharmaceuticals

9 followers

Othram

1 follower

Explore companies